DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Lian B, Si L, Cui C et al
Phase II randomized trial comparing high-dose IFN-α2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma.
Clin Cancer Res 2013;
19: 4488-4498
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.